PROKIDNEY CORP. — Director's Dealing 2025

Nov 14, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PROKIDNEY CORP. (PROK)
CIK: 0001850270
Period of Report: 2025-11-12

Reporting Person: Pereira Brian JG (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-11-12	Class A Common Stock	S	227431	$2.7233	Disposed	447803	Indirect
2025-11-12	Class A Common Stock	S	27595	$2.7234	Disposed	54333	Indirect
2025-11-13	Class A Common Stock	S	447803	$2.37	Disposed	0	Indirect
2025-11-13	Class A Common Stock	S	54333	$2.37	Disposed	0	Indirect

Footnotes

F1: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.70 to $2.88, inclusive. The reporting person undertakes to provide to ProKidney Corp., any security holder of ProKidney Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F2: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.25 to $2.66, inclusive. The reporting person undertakes to provide to ProKidney Corp., any security holder of ProKidney Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote